###begin article-title 0
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
Single nucleotide polymorphisms of the tenomodulin gene (TNMD) in age-related macular degeneration
###end article-title 0
###begin p 1
The first two authors contributed equally to this work.
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin title 3
Purpose
###end title 3
###begin p 4
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD)</italic>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
Tenomodulin (TNMD) is located in the X-chromosome encoding a putative angiogenesis inhibitor which is expressed in retina. Associations of single nucleotide polymorphisms of TNMD with the prevalence of age-related macular degeneration (AMD) were examined.
###end p 4
###begin title 5
Methods
###end title 5
###begin p 6
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 160 163 <span type="species:ncbi:9606">men</span>
###xml 172 177 <span type="species:ncbi:9606">women</span>
###xml 201 204 <span type="species:ncbi:9606">men</span>
###xml 212 217 <span type="species:ncbi:9606">women</span>
###xml 244 247 <span type="species:ncbi:9606">men</span>
###xml 256 261 <span type="species:ncbi:9606">women</span>
###xml 279 291 <span type="species:ncbi:9606">participants</span>
Six markers covering 75% of the common sequence variation in the coding region of TNMD and 10 kb up- and downstream were genotyped in a sample consisting of 89 men and 175 women with exudative AMD, 18 men and 25 women with atrophic AMD, and 55 men and 113 women without AMD. All participants were over 65 years old and did not have diabetes mellitus. Due to the chromosomal locus, the association of genotypes with AMD was assessed genderwise.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
###xml 63 68 <span type="species:ncbi:9606">women</span>
###xml 87 92 <span type="species:ncbi:9606">women</span>
###xml 119 124 <span type="species:ncbi:9606">women</span>
###xml 357 362 <span type="species:ncbi:9606">women</span>
###xml 410 415 <span type="species:ncbi:9606">women</span>
###xml 537 542 <span type="species:ncbi:9606">women</span>
###xml 650 655 <span type="species:ncbi:9606">women</span>
###xml 740 745 <span type="species:ncbi:9606">women</span>
Three markers, , , and , were associated with a risk of AMD in women. In comparison to women with other genotypes, the women who were homozygous for the minor allele (genotypes -TT or -CC) had 2.6 fold (p=0.021) or 1.9 fold (p=0.067) risk for having AMD, respectively. These differences were due to the unequal prevalence of exudative AMD. In comparison to women who were homozygous for the major alleles, the women with -TT genotype had a 2.8 fold risk (p=0.021 in additive model; p=0.022 in recessive model) for exudative AMD, and the women with -CC genotype had a 1.8 fold risk (p=0.09 in additive model; p=0.038 in recessive model). Furthermore, women carrying the rare -AA genotype had a significantly smaller risk for having AMD than women with the other genotypes (odds ratio 0.083; p=0.001 in recessive model), but due to the low frequency of this genotype, this finding must be interpreted cautiously. The false discovery rate was <10% for all of the aforementioned results.
###end p 8
###begin title 9
Conclusions
###end title 9
###begin p 10
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 114 119 <span type="species:ncbi:9606">women</span>
On the basis of the putative antiangiogenic role of TNMD and the present genetic associations of TNMD with AMD in women, we suggest that TNMD could be a novel candidate gene for AMD. These results should be confirmed in further studies.
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 551 552 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 651 652 651 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 963 964 963 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 965 967 965 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 1312 1313 1312 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 1314 1315 1314 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 1432 1433 1432 1433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 1434 1435 1434 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
Age-related macular degeneration (AMD) is the leading cause of irreversible visual loss in the elderly [1]. It is attributable to degenerative tissue alterations occurring at the interface between the neural retina and underlying choroid [2,3]. AMD can be divided into atrophic and exudative forms. The atrophic form is more common and accounts for approximately 80% of AMD cases. However, the exudative form accounts for the majority of advanced cases [4]. The disease etiology is multifactorial-i.e., in addition to a substantial genetic component [5], aging, smoking, high body mass index, hypertension, and hypercholesterolemia predispose to AMD [6-11]. Choroidal neovascularization and leakage from the blood vessels are diagnostic markers for exudative AMD. Oxidative stress, ischemia, or inflammation can induce proliferative processes in the choroidal endothelial cells, which then evokes the growth of new blood vessels into subretinal or retinal space [2,12]. A thickening, calcification, and fragmentation of Bruch's membrane may predispose to the development of choroidal neovascular membranes. The harmful new blood vessels that are diagnostic for exudative AMD grow through Bruch's membrane, where they can disrupt the membrane and leak blood or fluid into the subretinal pigment epithelial space [3,4]. This can evoke damage to the photoreceptor layer and result in vision abnormalities or even total loss of vision [3,4].
###end p 12
###begin p 13
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
The importance of genetic risk factors, specifically of those related to the complement system, has been highlighted in several studies. An association has been observed between the Y402H polymorphism () of the complement factor H gene and AMD in several populations [13-19]. Furthermore, an association between the LOC387715/HTRA1 locus and AMD in populations of different origin has been documented [20-28]. One common polymorphism () in the complement component 3 has also been associated with AMD [29,30]. Other putative candidates include genes related to fatty acid metabolism, such as apolipoprotein E [31,32], ATP-binding cassette, subfamily A, member 4 [33,34], and elongation of very long chain fatty acids-like 4 [18], but their roles in the pathogenesis of AMD are controversial.
###end p 13
###begin p 14
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 384 388 384 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 739 743 739 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 847 849 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 922 926 922 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 1053 1055 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r41">41</xref>
###xml 1125 1127 1125 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 1153 1155 1153 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r43">43</xref>
###xml 1250 1254 1250 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 1339 1340 1339 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 1366 1371 1366 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DIAPH</italic>
###xml 1469 1471 1469 1471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r44">44</xref>
###xml 1532 1536 1532 1536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 370 375 <span type="species:ncbi:10090">mouse</span>
###xml 754 758 <span type="species:ncbi:10090">mice</span>
###xml 1341 1351 <span type="species:ncbi:7227">Drosophila</span>
Since dysregulated neovascularization is involved in the pathogenesis of AMD, the angiogenesis regulators represent interesting candidate genes. Tenomodulin (TNMD) is a type II transmembrane glycoprotein containing a C-terminal domain with homology to chondromodulin-I, which is a cartilage-derived angiogenesis inhibitor [35-37]. During the late developmental phase of mouse embryo, TNMD mRNA is expressed in the tendon of extraocular muscles, cornea, sensory retina, sclera, lens epithelial cells at the equator, and in the differentiating secondary lens fiber cells [38]. TNMD has been reported to inhibit angiogenesis by hindering endothelial proliferation and tube formation [38,39], but this has not been confirmed in vivo since the TNMD-deficient mice did not exhibit any vascular abnormalities when examined by oxygen-induced retinopathy [40]. Recent results suggest that single nucleotide polymorphisms (SNPs) of TNMD are associated with obesity, disturbed glucose metabolism, and conversion from impaired glucose tolerance to type 2 diabetes [41] as well as with elevated serum levels of systemic immune mediators [42] and serum lipoproteins [43]. Due to these connections with vascularization, inflammation, lipid metabolism, and obesity, TNMD is an interesting potential new candidate gene for AMD. In addition, the diaphanous 2 Drosophila homolog gene (DIAPH), located in the same cytogenetic band Xq-22, has been linked to AMD in a study by Zheng et al. [44]. In the present study, we investigated the associations of TNMD SNPs with AMD.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Subjects
###end title 16
###begin p 17
###xml 60 63 <span type="species:ncbi:9606">men</span>
###xml 69 74 <span type="species:ncbi:9606">women</span>
###xml 91 94 <span type="species:ncbi:9606">men</span>
###xml 103 108 <span type="species:ncbi:9606">women</span>
###xml 135 138 <span type="species:ncbi:9606">men</span>
###xml 146 151 <span type="species:ncbi:9606">women</span>
###xml 170 178 <span type="species:ncbi:9606">Patients</span>
###xml 488 491 <span type="species:ncbi:9606">men</span>
###xml 500 505 <span type="species:ncbi:9606">women</span>
###xml 511 523 <span type="species:ncbi:9606">participants</span>
###xml 743 755 <span type="species:ncbi:9606">participants</span>
The study population consisted of 475 Finnish subjects (162 men, 313 women). A total of 89 men and 175 women had exudative AMD, and 18 men and 25 women had atrophic AMD. Patients with choroidal neovascularization attributable to AMD were given their diagnosis based on fundus photographs and fluorescein angiography in the Department of Ophthalmology of Kuopio University Hospital or Helsinki University Hospital. The control group (no signs of AMD in fundus photographs) consisted of 55 men and 113 women. All participants were over 65 years old and did not have diabetes mellitus. The study was approved by the Ethics Committee of the Helsinki University Eye and Ear Hospital and the tenets of the Declaration of Helsinki were followed. All participants signed an informed consent form. Eligibility criteria was based on biomicroscopy examination, fundus photographs and fluorescein angiography which were performed before the study. The blood samples were stored in -80 degreesC until DNA isolation. DNA was extracted from peripheral blood leucocytes by salt precipitation.
###end p 17
###begin title 18
Genotype analysis
###end title 18
###begin p 19
###xml 64 65 64 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r45">45</xref>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r41">41</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
Six markers covering 75% of the common sequence variation with r2>0.8 in the coding region of TNMD (15 kb) and 10 kb upstream and downstream from the coding region (35 kb) were selected with the  algorithm [45]. The markers  and , associated with an increased risk of type 2 diabetes [41] and elevated concentrations of serum acute phase reactants [42] in our previous studies, were included in the selection procedure.
###end p 19
###begin p 20
Genotyping was performed with TaqMan Allelic Discrimination Assay according to the manufacturer's instructions using ABI Prism 7000 sequence detector (Applied Biosystems, Foster City, CA). The genotyping success rate was 98.5% for , 99.6% for , and 100% for the markers , , , and . The error rate for genotyping was calculated by repeating a subset of randomly selected samples representing 6.3% of the study cohort. The error rate was 0% for all markers.
###end p 20
###begin title 21
Statistics
###end title 21
###begin p 22
###xml 20 22 20 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r46">46</xref>
###xml 216 220 216 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 671 672 669 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 740 742 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r47">47</xref>
###xml 858 859 855 856 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 942 944 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r48">48</xref>
###xml 1010 1011 1002 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 374 379 <span type="species:ncbi:9606">women</span>
Haploview software [46] was used for linkage disequilibrium (LD) and Hardy-Weinberg equilibrium analysis, and association studies were performed with SPSS 14.0 for Windows (SPSS, Chicago, IL). The association of the TNMD SNPs with the prevalence of AMD was tested with logistic regression analysis. Due to the X-chromosomal location, a genderwise analysis was performed. In women, the association with the prevalence of AMD was assessed with additive, dominant (major allele homozygotes versus other genotypes), and recessive (minor allele homozygotes versus other genotypes) models. The genderwise differences in minor allele frequencies (MAF) were assessed with the chi2-test. Haplotype analyses were performed with Thesias 3.1 software [47]. Correction for multiple hypothesis testing was performed with false discovery rate using Q-value 1.0 software. pi0 was estimated with the bootstrap method using lambda range from 0 to 0.9 by 0.05 [48]. The false discovery rate for each p-value <0.1 was reported as q.
###end p 22
###begin title 23
Results
###end title 23
###begin p 24
###xml 263 271 263 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 326 333 326 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
All markers, except  (p=0.002) were in Hardy-Weinberg equilibrium. This exception was unlikely due to a genotyping error, as confirmed by genotyping a random subsample of the study population. The pairwise LD pattern and positions of the markers are presented in Figure 1. The genderwise minor allele frequencies are shown in Table 1.
###end p 24
###begin p 25
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
Location of the selected markers along the TNMD gene and their pairwise linkage disequilibrium pattern, indicated by D'- (upper) and r2-values (lower). Two haploblocks, defined by solid spine of linkage disequilibrium are denoted by gray shading. The first haploblock consists of markers  and , and the second consists of  and .
###end p 25
###begin title 26
The genderwise minor allele frequencies of the genotyped markers.
###end title 26
###begin p 27
###xml 191 194 <span type="species:ncbi:9606">men</span>
###xml 199 204 <span type="species:ncbi:9606">women</span>
###xml 251 256 <span type="species:ncbi:9606">women</span>
The minor allele frequencies (MAF) of  and  did not differ between the genders. A minor difference was observed in the MAF of  and  while the MAF of  and  differed more significantly between men and women. Markers , , and  were associated with AMD in women.
###end p 27
###begin p 28
###xml 3 8 <span type="species:ncbi:9606">women</span>
###xml 176 181 <span type="species:ncbi:9606">women</span>
###xml 219 224 <span type="species:ncbi:9606">women</span>
###xml 294 299 <span type="species:ncbi:9606">women</span>
###xml 385 390 <span type="species:ncbi:9606">women</span>
###xml 430 435 <span type="species:ncbi:9606">women</span>
###xml 462 467 <span type="species:ncbi:9606">women</span>
###xml 608 613 <span type="species:ncbi:9606">women</span>
###xml 704 709 <span type="species:ncbi:9606">women</span>
In women, the markers  and  were associated with total prevalence (atrophic or exudative form) of AMD, and a trend was observed with . The odds ratios (OR) of the heterozygous women were similar to those observed among women who were major allele homozygotes (data not shown). In contrast, the women homozygous for the minor alleles had significantly different ORs for having AMD than women with other genotypes. In comparison to women with other genotypes, the women who were homozygous for either of the minor alleles -TT or -CC, had 2.6 fold or 1.9 fold risk for having AMD, respectively (). In addition, women with the rare -AA genotype displayed a significantly smaller risk for having AMD than the women with the other genotypes (odds ratio=0.083, ).
###end p 28
###begin p 29
###xml 702 709 702 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 866 867 866 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
###xml 122 127 <span type="species:ncbi:9606">women</span>
###xml 203 208 <span type="species:ncbi:9606">women</span>
###xml 278 283 <span type="species:ncbi:9606">women</span>
###xml 372 377 <span type="species:ncbi:9606">women</span>
###xml 442 447 <span type="species:ncbi:9606">women</span>
###xml 527 532 <span type="species:ncbi:9606">women</span>
###xml 581 586 <span type="species:ncbi:9606">women</span>
###xml 697 700 <span type="species:ncbi:9606">men</span>
In more specific terms, these differences were due to the unequal prevalence of exudative AMD in the genotype groups. The women with -CC genotype had a 2.1 fold risk (p=0.038) for exudative AMD, and the women with -TT genotype had a 2.6 fold risk (p=0.022) in comparison to the women with other genotypes of the same markers (p values refer to the recessive model; ). The women with -AA genotype had a significantly smaller risk for AMD than women with -TT or -TA genotypes (p=0.002; recessive model, ). The OR of heterozygous women did not differ between those observed among the women who were homozygous for the major allele (). None of the markers were associated with prevalence of AMD among men (Table 2). The false discovery rate was less than 10% for all of the abovementioned associations and less than 5%, apart from that of  with total prevalence of AMD (q=0.067).
###end p 29
###begin title 30
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 80 83 <span type="species:ncbi:9606">men</span>
The associations of the selected markers of the TNMD gene with exudative AMD in men.
###end title 30
###begin p 31
###xml 123 126 <span type="species:ncbi:9606">men</span>
Abbreviations: odds ratio (OR); confidence interval (CI). None of the markers was associated with the prevalence of AMD in men.
###end p 31
###begin p 32
###xml 481 488 481 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 340 345 <span type="species:ncbi:9606">women</span>
Haplotype analyses were performed according to the two LD-based haploblocks, one consisting of  and  and the other involving  and . Additional analyses were performed for combinations of individual markers that were associated with AMD (,  and ). The results of haplotype analyses were in line with the results of single marker analyses in women, but neither of these approaches revealed a haplotype that would explain the results substantially better than the individual markers (Table 3).
###end p 32
###begin title 33
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 97 102 <span type="species:ncbi:9606">women</span>
Associations of the TNMD haplotypes with total AMD (exudative and atrophic) and exudative AMD in women.
###end title 33
###begin p 34
###xml 167 172 <span type="species:ncbi:9606">women</span>
Haploblocks 1 and 2 are defined on the basis of solid spine of LD. In addition, a 3-marker haplotype was constructed of those markers that were associated with AMD in women. The haplotype analyses did not reveal a haplotype that would explain the results substantially better than the single-marker analyses. Abbreviations: odds ratio (OR); confidence interval (CI).
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 1019 1026 1019 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 126 131 <span type="species:ncbi:9606">women</span>
###xml 223 228 <span type="species:ncbi:9606">women</span>
###xml 377 382 <span type="species:ncbi:9606">women</span>
###xml 482 485 <span type="species:ncbi:9606">men</span>
###xml 584 589 <span type="species:ncbi:9606">women</span>
###xml 655 660 <span type="species:ncbi:9606">women</span>
###xml 1237 1243 <span type="species:ncbi:9606">people</span>
According to the results of the present study, genetic variation in the TNMD gene is associated with the prevalence of AMD in women. The genotypes -CC and -TT that associated with a higher prevalence of exudative AMD among women in the present study (), were linked with higher serum concentrations of macrophage migration inhibitory factor and chemokine, CC motif ligand 5 in women [42]. The same markers were associated with higher serum acute phase reactant concentrations among men [42]. In addition, the -AA genotype was associated with a lower prevalence of exudative AMD among women (), but due to the low frequency of this genotype (16 out of 313 women), this finding must be interpreted cautiously. We did not observe associations with atrophic AMD, which was likely due to the small number of cases as the main aim of the study was to detect genetic risk factors for exudative AMD. In addition to single-marker analyses, haplotype analyses was performed, but they did not provide additional information ( and Table 3). This may be because the distribution of haplotypes that contained the individual risk alleles was almost identical to the individual allele frequencies. Since there were some missing genotypes, the number of people in the haplotype analysis was slightly lower than in the single marker analyses. This may also account for the weaker associations observed in the haplotype analyses.
###end p 36
###begin p 37
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r49">49</xref>
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r50">50</xref>
###xml 392 396 392 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 445 449 445 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r51">51</xref>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r52">52</xref>
###xml 249 254 <span type="species:ncbi:9606">women</span>
###xml 327 332 <span type="species:ncbi:9606">women</span>
###xml 364 367 <span type="species:ncbi:9606">men</span>
###xml 593 598 <span type="species:ncbi:9606">women</span>
###xml 667 670 <span type="species:ncbi:9606">men</span>
###xml 844 847 <span type="species:ncbi:9606">men</span>
###xml 852 857 <span type="species:ncbi:9606">women</span>
###xml 1030 1033 <span type="species:ncbi:9606">men</span>
###xml 1116 1119 <span type="species:ncbi:9606">men</span>
###xml 1390 1393 <span type="species:ncbi:9606">men</span>
###xml 1398 1403 <span type="species:ncbi:9606">women</span>
###xml 1546 1551 <span type="species:ncbi:9606">women</span>
The gender difference may arise from the genetic locus (Xq-22). The expression and function of X-chromosomal genes differ between genders, partially because of the variation in gene dosages and the random inactivation of one of the X-chromosomes in women [49]. Since the expression levels of TNMD mRNA in the adipose tissue of women are double that encountered in men [50], it seems that the TNMD locus is able to escape the X-inactivation. The TNMD locus is also relatively distant from the X-inactivation center. Genomic imprinting can also result in different gene expression levels, since women are normally mosaic for maternal and paternal active X-chromosomes; men harbor only the maternal X-chromosome and therefore express the maternally inherited genes in that locus [51]. In addition, the cellular microenvironment can differ between men and women, due to differences in hormone levels and gene expression [52]. However, we cannot rule out the possibility that the study was underpowered to detect these associations in men. The observed differences in proportions were smaller than 0.1, and the number of men included in this study population was probably not high enough to detect differences of this magnitude. The MAF distribution of  was similar in both genders and therefore the association of  with AMD does not result from the imbalance in the allele distribution between men and women. Gender differences were observed in the MAF of  and . It is difficult to speculate whether the associations of  and , which were observed in women, result from gender differences in MAFs; differences of equal magnitude were observed with two other markers ( and ) that were not associated with the prevalence of AMD.
###end p 37
###begin p 38
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 313 318 313 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD.</italic>
###xml 896 898 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 899 901 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r53">53</xref>
###xml 902 904 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r54">54</xref>
###xml 1020 1022 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r54">54</xref>
###xml 1129 1131 1129 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r55">55</xref>
###xml 1132 1134 1132 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r58">58</xref>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 390 394 <span type="species:ncbi:10090">mice</span>
###xml 539 544 <span type="species:ncbi:9606">human</span>
In vivo experiments in mice with oxygen-induced retinopathy have revealed that a lack of TNMD does not result in abnormal angiogenesis or retinal neovascularization [40]. Since the regulation of angiogenesis is a multifactorial process, it is possible that other factors might have compensated for the absence of TNMD. The age-associated factors can also vary between species. In addition, mice lack the normal macula and cones and therefore the regulation of retinal neovascularization in that species might be different from that in the human eye. In exudative AMD, neovascularization is evoked by a proliferation of abnormal choroidal blood vessels behind the retina. The multifactorial etiology of vascular dysregulation in AMD is not fully understood, but the expression levels of many stimulatory and inhibitory regulators of neovascularization are known to be altered during pathogenesis [12,53,54]. For example, vascular endothelial growth factor (VEGF), is known to be involved in choroidal neovascularization [54] and accordingly, VEGF-blocking compounds are emerging as highly successful treatments for exudative AMD [55-58]. This provides further evidence for the importance of angiogenesis regulators in AMD and supports the theory of a disrupted balance between stimulators and inhibitors of neovascularization in the pathogenesis of exudative AMD.
###end p 38
###begin p 39
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r59">59</xref>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r62">62</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r63">63</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r64">64</xref>
###xml 367 371 367 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 644 648 644 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 814 820 814 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DIAPH2</italic>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r44">44</xref>
###xml 613 618 <span type="species:ncbi:9606">women</span>
The genetic association studies on the role of VEGF polymorphisms in exudative AMD have delivered conflicting results [59-62], but interestingly, polymorphisms of the gene encoding antiangiogenic pigment epithelial growth factor have been linked to AMD [63,64]. In relation to these previous association studies with angiogenesis regulators, the associations between TNMD sequence variation and exudative AMD point to an interesting hypothesis on the regulatory role of TNMD in choroidal neovascularization and exudative AMD. It is important to note that the false discovery rate for the associations observed in women was low, suggesting that TNMD is a promising new candidate gene for AMD. The same cytogenetic band has been linked to AMD by Zheng et al., who also reported gender-specific associations with the DIAPH2 [44]. Therefore, despite the lack of a replication sample, our results are supported by the findings of this previous study. We recognize the need for the replication of these findings in other study populations. Functional studies are needed to reveal the potential mechanisms accounting for these associations.
###end p 39
###begin title 40
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 53 58 <span type="species:ncbi:9606">women</span>
Appendix 1. The association of TNMD SNPs with AMD in women.
###end title 40
###begin p 41
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNMD</italic>
###xml 491 492 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q</italic>
The associations of the selected markers of the TNMD gene with the prevalence of total (athropic or exudative) and exudative AMD are reported according to additive and recessive (minor allele homozygotes versus other genotypes) models. False discovery rate (q) is indicated only for p<0.1. The markers , , and  were associated with total and exudative AMDTo access the data, click or select the words "." This will initiate the download of a pdf that contains the file. False discovery rate q is reported only for p<0.1. Abbreviations: odds ratio (OR); confidence interval (CI).
###end p 41
###begin title 42
Acknowledgments
###end title 42
###begin p 43
We gratefully acknowledge Ms. Paivi Turunen for excellent technical assistance. This study was funded by the Finnish Graduate School on Applied Bioscience: Bioengineering, Food and Nutrition, Environment (A.M.T.), Sigrid Juselius Foundation, Academy of Finland (grants 117844, 211497, M.U.; 209445, M.K.), the EVO fund of the Kuopio University Hospital (5179 and 5198, M.U.; 5503709, T.N.), from the Ministry of Health and Social Affairs, Emil Aaltonen Foundation (K.K.), the Finnish Cultural Foundation and its North Savo Fund (K.K.), the Finnish Eye Foundation (K.K., T.N.), the Finnish Eye and Tissue Bank Foundation (K.K.), and the Finnish Funding Agency for Technology and Innovation (K.K.).
###end p 43
###begin title 44
References
###end title 44
###begin article-title 45
The role of oxidative stress in the pathogenesis of age-related macular degeneration.
###end article-title 45
###begin article-title 46
Age-related macular degeneration-emerging pathogenetic and therapeutic concepts.
###end article-title 46
###begin article-title 47
The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences.
###end article-title 47
###begin article-title 48
Family history and age-related maculopathy: the Blue Mountains Eye Study.
###end article-title 48
###begin article-title 49
Risk factors for age-related macular degeneration: an update.
###end article-title 49
###begin article-title 50
Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study.
###end article-title 50
###begin article-title 51
Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study.
###end article-title 51
###begin article-title 52
Epidemiology of agerelated maculopathy: a review.
###end article-title 52
###begin article-title 53
The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study.
###end article-title 53
###begin article-title 54
The role of inflammation in the pathogenesis of age-related macular degeneration.
###end article-title 54
###begin article-title 55
Complement factor H polymorphism and age-related macular degeneration.
###end article-title 55
###begin article-title 56
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.
###end article-title 56
###begin article-title 57
Complement factor H variant increases the risk of age-related macular degeneration.
###end article-title 57
###begin article-title 58
Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population.
###end article-title 58
###begin article-title 59
###xml 126 134 <span type="species:ncbi:9606">patients</span>
Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients.
###end article-title 59
###begin article-title 60
Analysis of variants in the complement factor H, the elongation of very long chain fatty acids-like 4 and the hemicentin 1 genes of age-related macular degeneration in the Finnish population.
###end article-title 60
###begin article-title 61
Multifactor effects and evidence of potential interaction between complement factor H Y402H and LOC387715 A69S in age-related macular degeneration.
###end article-title 61
###begin article-title 62
Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk.
###end article-title 62
###begin article-title 63
The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples.
###end article-title 63
###begin article-title 64
A polymorphism of LOC387715 gene is associated with age-related macular degeneration in the Japanese population.
###end article-title 64
###begin article-title 65
A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration.
###end article-title 65
###begin article-title 66
HTRA1 variant increases risk to neovascular age-related macular degeneration in Chinese population.
###end article-title 66
###begin article-title 67
HTRA1 promoter polymorphism in wet age-related macular degeneration.
###end article-title 67
###begin article-title 68
Association of the HTRA1 gene variant with age-related macular degeneration in the Japanese population.
###end article-title 68
###begin article-title 69
HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration.
###end article-title 69
###begin article-title 70
Association of the HTRA1 -625G>A promoter gene polymorphism with exudative age-related macular degeneration in a Central European population.
###end article-title 70
###begin article-title 71
Complement C3 variant and the risk of age-related macular degeneration.
###end article-title 71
###begin article-title 72
Variation in complement factor 3 is associated with risk of age-related macular degeneration.
###end article-title 72
###begin article-title 73
A pooled casecontrol study of the apolipoprotein E (APOE) gene in age-related maculopathy.
###end article-title 73
###begin article-title 74
Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center.
###end article-title 74
###begin article-title 75
A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration.
###end article-title 75
###begin article-title 76
Simple and complex ABCR: genetic predisposition to retinal disease.
###end article-title 76
###begin article-title 77
Molecular cloning of tenomodulin, a novel chondromodulin-I related gene.
###end article-title 77
###begin article-title 78
Molecular cloning and characterization of CHM1L, a novel membrane molecule similar to chondromodulin-I.
###end article-title 78
###begin article-title 79
A novel gene, tendin, is strongly expressed in tendons and ligaments and shows high homology with chondromodulin-I.
###end article-title 79
###begin article-title 80
###xml 117 122 <span type="species:ncbi:10090">mouse</span>
Expression and localization of tenomodulin, a transmembrane type chondromodulin-I-related angiogenesis inhibitor, in mouse eyes.
###end article-title 80
###begin article-title 81
Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I.
###end article-title 81
###begin article-title 82
Tenomodulin is necessary for tenocyte proliferation and tendon maturation.
###end article-title 82
###begin article-title 83
Tenomodulin is associated with obesity and diabetes risk: the Finnish Diabetes Prevention Study.
###end article-title 83
###begin article-title 84
The genetic variation of the tenomodulin gene (TNMD) is associated with serum levels of systemic immune mediators-the Finnish Diabetes Prevention Study.
###end article-title 84
###begin article-title 85
The genetic variation in the tenomodulin gene is associated with serum total and LDL cholesterol in a body size-dependent manner.
###end article-title 85
###begin article-title 86
Testing association for markers on the X chromosome.
###end article-title 86
###begin article-title 87
Efficiency and power in genetic association studies.
###end article-title 87
###begin article-title 88
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 88
###begin article-title 89
A new algorithm for haplotypebased association analysis: the Stochastic-EM algorithm.
###end article-title 89
###begin article-title 90
Statistical significance for genomewide studies.
###end article-title 90
###begin article-title 91
X-inactivation profile reveals extensive variability in X-linked gene expression in females.
###end article-title 91
###begin article-title 92
Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study.
###end article-title 92
###begin article-title 93
Maternal X chromosome, visceral adiposity, and lipid profile.
###end article-title 93
###begin article-title 94
Sexual dimorphism in mammalian gene expression.
###end article-title 94
###begin article-title 95
Current concepts in the pathogenesis of age-related macular degeneration.
###end article-title 95
###begin article-title 96
The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration.
###end article-title 96
###begin article-title 97
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer.
###end article-title 97
###begin article-title 98
Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration.
###end article-title 98
###begin article-title 99
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
###end article-title 99
###begin article-title 100
Ranibizumab for neovascular age-related macular degeneration.
###end article-title 100
###begin article-title 101
Polymorphisms in the vascular endothelial growth factor gene and risk of age-related macular degeneration: the Rotterdam Study.
###end article-title 101
###begin article-title 102
VEGF polymorphisms are associated with neovascular age-related macular degeneration.
###end article-title 102
###begin article-title 103
Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration.
###end article-title 103
###begin article-title 104
Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6.
###end article-title 104
###begin article-title 105
Pigment epithelium-derived factor gene Met72Thr polymorphism is associated with increased risk of wet age-related macular degeneration.
###end article-title 105
###begin article-title 106
Met72Thr polymorphism of pigment epithelium-derived factor gene and susceptibility to age-related macular degeneration.
###end article-title 106

